Intrinsic Value of S&P & Nasdaq Contact Us

Intuitive Surgical, Inc. ISRG NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
81/100
6/7 Pass
SharesGrow Intrinsic Value
$259.27
-44.5%
Analyst Price Target
$638.75
+36.7%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Intuitive Surgical, Inc. (ISRG) has shown strong revenue growth over the past 3 years, expanding from $6.2B to $10.1B (average +17.4%/yr). Net income reached $2.9B, reflecting exceptional earnings expansion at +29.4%/yr on average. The net profit margin is 28.4%, which is exceptional. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 66% (high), with a -1.4pp trend over the period. With a $166B market cap and MOAT composite score of 86/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (90/100, Pass) — proving strong growth momentum
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 28-year history, the company was profitable in 22 of 28 years — a solid long-term record with occasional losses
  • INCOME (85/100, Pass) — proves strong profitability and pricing power
  • MOAT (86/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 81/100 with 6/7 criteria passed.

81/100
SG Score
View full scorecard →
VALUE
31/100
Price-to-Earnings & upside
→ IV page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $7.87
Proven by this page
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
86/100
Score: 86/100
GM 66% (-1.4pp)
Proven by this page
GROWTH
90/100
Rev +17.4%/yr
NI +29.4%/yr
Proven by this page
INCOME
85/100
Margin 28.4%
$10.1B
Proven by this page
Intuitive Surgical, Inc. Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $10.06B$10.06B$8.35B$7.12B$6.22B
Gross Profit $6.64B$6.64B$5.63B$4.73B$4.2B
Gross Margin 66%66%67.5%66.4%67.4%
Operating Income $2.95B$2.95B$2.35B$1.77B$1.21B
Net Income $2.86B$2.86B$2.32B$1.8B$1.32B
Net Margin 28.4%28.4%27.8%25.2%21.3%
EPS (Diluted) $7.89$7.87$6.42$5.03$3.65
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message